Stimulation of κ2- And σ-Receptors as a Possible Approach to Prevention of Myocardial Dysfunction Caused by Reperfusion

Yu B. Lishmanov, L. N. Maslov, S. W. Tam

Research output: Contribution to journalArticle

Abstract

It was found that intravenous administration of σ-receptor agonists (+)-SKF 10047 and (+)-bremazocine or κ2-agonist (-)-bremazocine resulted in increased tolerance of isolated perfused rat heart to ischemic and reperfusion damages. Both κ2- and σ-receptor stimulation prevented the development of reperfusion contracture, increased left ventricular developed pressure, the double product, +dP/dt and -dP/dt. Only σ-receptor agonists (d-SKF 10047 and d-bremazocine) prevented arrhythmias caused by reoxygenation. By contrast, only κ2-agonist (-)-bremazocine prevented development of reperfusion no-reflow phenomenon in vitro and increased tolerance of the heart to arrhythmogenic action of epinephrine in vivo. Of the three compounds tested, only (+)-SKF 10047 abolished reoxygenation cell membrane injuries. Thus activation of cardiac σ- and κ2-receptors might be useful for prevention of myocardial stunning. Stimulation of σ- and κ2-receptors can be used for protection of the heart against arrhythmogenic action of reperfusion and adrenergic agents, respectively. κ2-receptor agonists can be used for prevention of no-reflow phenomenon and σ-receptor agonist (+)-SKF 10047 -for protection against cardiac sarcolemma injury.

Original languageEnglish
Pages (from-to)70-76
Number of pages7
JournalKardiologiya
Volume41
Issue number1
Publication statusPublished - 2001

Fingerprint

Reperfusion
No-Reflow Phenomenon
Myocardial Stunning
Sarcolemma
Wounds and Injuries
Contracture
Ventricular Pressure
Reperfusion Injury
Intravenous Administration
Adrenergic Agents
Epinephrine
Cardiac Arrhythmias
Cell Membrane
SK&F 10047
bremazocine

Keywords

  • Kappa
  • Myocardial reperfusion
  • Opioid receptors
  • Sigma
  • Stunning

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Stimulation of κ2- And σ-Receptors as a Possible Approach to Prevention of Myocardial Dysfunction Caused by Reperfusion. / Lishmanov, Yu B.; Maslov, L. N.; Tam, S. W.

In: Kardiologiya, Vol. 41, No. 1, 2001, p. 70-76.

Research output: Contribution to journalArticle

@article{f0a0ca559d1b4c4d93ea9adddb54aaa3,
title = "Stimulation of κ2- And σ-Receptors as a Possible Approach to Prevention of Myocardial Dysfunction Caused by Reperfusion",
abstract = "It was found that intravenous administration of σ-receptor agonists (+)-SKF 10047 and (+)-bremazocine or κ2-agonist (-)-bremazocine resulted in increased tolerance of isolated perfused rat heart to ischemic and reperfusion damages. Both κ2- and σ-receptor stimulation prevented the development of reperfusion contracture, increased left ventricular developed pressure, the double product, +dP/dt and -dP/dt. Only σ-receptor agonists (d-SKF 10047 and d-bremazocine) prevented arrhythmias caused by reoxygenation. By contrast, only κ2-agonist (-)-bremazocine prevented development of reperfusion no-reflow phenomenon in vitro and increased tolerance of the heart to arrhythmogenic action of epinephrine in vivo. Of the three compounds tested, only (+)-SKF 10047 abolished reoxygenation cell membrane injuries. Thus activation of cardiac σ- and κ2-receptors might be useful for prevention of myocardial stunning. Stimulation of σ- and κ2-receptors can be used for protection of the heart against arrhythmogenic action of reperfusion and adrenergic agents, respectively. κ2-receptor agonists can be used for prevention of no-reflow phenomenon and σ-receptor agonist (+)-SKF 10047 -for protection against cardiac sarcolemma injury.",
keywords = "Kappa, Myocardial reperfusion, Opioid receptors, Sigma, Stunning",
author = "Lishmanov, {Yu B.} and Maslov, {L. N.} and Tam, {S. W.}",
year = "2001",
language = "English",
volume = "41",
pages = "70--76",
journal = "Kardiologiya",
issn = "0022-9040",
publisher = "Media Sfera",
number = "1",

}

TY - JOUR

T1 - Stimulation of κ2- And σ-Receptors as a Possible Approach to Prevention of Myocardial Dysfunction Caused by Reperfusion

AU - Lishmanov, Yu B.

AU - Maslov, L. N.

AU - Tam, S. W.

PY - 2001

Y1 - 2001

N2 - It was found that intravenous administration of σ-receptor agonists (+)-SKF 10047 and (+)-bremazocine or κ2-agonist (-)-bremazocine resulted in increased tolerance of isolated perfused rat heart to ischemic and reperfusion damages. Both κ2- and σ-receptor stimulation prevented the development of reperfusion contracture, increased left ventricular developed pressure, the double product, +dP/dt and -dP/dt. Only σ-receptor agonists (d-SKF 10047 and d-bremazocine) prevented arrhythmias caused by reoxygenation. By contrast, only κ2-agonist (-)-bremazocine prevented development of reperfusion no-reflow phenomenon in vitro and increased tolerance of the heart to arrhythmogenic action of epinephrine in vivo. Of the three compounds tested, only (+)-SKF 10047 abolished reoxygenation cell membrane injuries. Thus activation of cardiac σ- and κ2-receptors might be useful for prevention of myocardial stunning. Stimulation of σ- and κ2-receptors can be used for protection of the heart against arrhythmogenic action of reperfusion and adrenergic agents, respectively. κ2-receptor agonists can be used for prevention of no-reflow phenomenon and σ-receptor agonist (+)-SKF 10047 -for protection against cardiac sarcolemma injury.

AB - It was found that intravenous administration of σ-receptor agonists (+)-SKF 10047 and (+)-bremazocine or κ2-agonist (-)-bremazocine resulted in increased tolerance of isolated perfused rat heart to ischemic and reperfusion damages. Both κ2- and σ-receptor stimulation prevented the development of reperfusion contracture, increased left ventricular developed pressure, the double product, +dP/dt and -dP/dt. Only σ-receptor agonists (d-SKF 10047 and d-bremazocine) prevented arrhythmias caused by reoxygenation. By contrast, only κ2-agonist (-)-bremazocine prevented development of reperfusion no-reflow phenomenon in vitro and increased tolerance of the heart to arrhythmogenic action of epinephrine in vivo. Of the three compounds tested, only (+)-SKF 10047 abolished reoxygenation cell membrane injuries. Thus activation of cardiac σ- and κ2-receptors might be useful for prevention of myocardial stunning. Stimulation of σ- and κ2-receptors can be used for protection of the heart against arrhythmogenic action of reperfusion and adrenergic agents, respectively. κ2-receptor agonists can be used for prevention of no-reflow phenomenon and σ-receptor agonist (+)-SKF 10047 -for protection against cardiac sarcolemma injury.

KW - Kappa

KW - Myocardial reperfusion

KW - Opioid receptors

KW - Sigma

KW - Stunning

UR - http://www.scopus.com/inward/record.url?scp=0346507507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346507507&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0346507507

VL - 41

SP - 70

EP - 76

JO - Kardiologiya

JF - Kardiologiya

SN - 0022-9040

IS - 1

ER -